ArticleiScience2026

Lomitapide mesylate and lomitapide target ALDOA to inhibit growth and enhance gemcitabine efficacy in PDAC.

Yan-Jie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.